Anti-BMP8A functional antibody

Anti-BMP8A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to BMP8A/BMP8A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0687-Ab-1/ GM-Tg-hg-SE0687-Ab-2Anti-Human BMP8A monoclonal antibodyHuman
GM-Tg-rg-SE0687-Ab-1/ GM-Tg-rg-SE0687-Ab-2Anti-Rat BMP8A monoclonal antibodyRat
GM-Tg-mg-SE0687-Ab-1/ GM-Tg-mg-SE0687-Ab-2Anti-Mouse BMP8A monoclonal antibodyMouse
GM-Tg-cynog-SE0687-Ab-1/ GM-Tg-cynog-SE0687-Ab-2Anti-Cynomolgus/ Rhesus macaque BMP8A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0687-Ab-1/ GM-Tg-felg-SE0687-Ab-2Anti-Feline BMP8A monoclonal antibodyFeline
GM-Tg-cang-SE0687-Ab-1/ GM-Tg-cang-SE0687-Ab-2Anti-Canine BMP8A monoclonal antibodyCanine
GM-Tg-bovg-SE0687-Ab-1/ GM-Tg-bovg-SE0687-Ab-2Anti-Bovine BMP8A monoclonal antibodyBovine
GM-Tg-equg-SE0687-Ab-1/ GM-Tg-equg-SE0687-Ab-2Anti-Equine BMP8A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0687-Ab-1/ GM-Tg-hg-SE0687-Ab-2; GM-Tg-rg-SE0687-Ab-1/ GM-Tg-rg-SE0687-Ab-2;
GM-Tg-mg-SE0687-Ab-1/ GM-Tg-mg-SE0687-Ab-2; GM-Tg-cynog-SE0687-Ab-1/ GM-Tg-cynog-SE0687-Ab-2;
GM-Tg-felg-SE0687-Ab-1/ GM-Tg-felg-SE0687-Ab-2; GM-Tg-cang-SE0687-Ab-1/ GM-Tg-cang-SE0687-Ab-2;
GM-Tg-bovg-SE0687-Ab-1/ GM-Tg-bovg-SE0687-Ab-2; GM-Tg-equg-SE0687-Ab-1/ GM-Tg-equg-SE0687-Ab-2
Products NameAnti-BMP8A monoclonal antibody
Formatmab
Target NameBMP8A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BMP8A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0687-Ag-1Recombinant multi-species BMP8A protein
    CytokineGM-Tg-g-SE0687-Ag-1bone morphogenetic protein 8a (BMP8A) protein


    Target information

    Target IDGM-SE0687
    Target NameBMP8A
    Gene ID353500,12163,680931,101089375
    Gene Symbol and SynonymsBmp7r1,BMP8A,OP-2,OP2
    Uniprot AccessionQ7Z5Y6
    Uniprot Entry NameBMP8A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000183682
    Target ClassificationN/A

    The target: BMP8A, gene name: BMP8A, also named as . This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein may play a role in development of the reproductive system. This gene may have arose from a gene duplication event and its gene duplicate is also present on chromosome 1. [provided by RefSeq, Jul 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.